Abstract
Get full access to this article
View all access options for this article.
References
1.
Benedetti
F
,
Cavallaro
R
,
Smeraldi
E
. Olanzapine-induced neutropenia after clozapine-induced neutropenia . Lancet , 254 :567 . 1999 .
2.
Clark
N
,
Weissberg
E
,
Noel
J
. Quetiapine and leukopenia . AM J Psychiatry , 158 :817 –818 . 2001 .
3.
Cowan
C
,
Oakley
C
. Leukopenia and neutropenia induced by quetiapine . Progress in Neuro-Psychopharmacology & Biological Psychiatry , 31 :292 –294 . 2007 .
4.
Dettling
M
,
Cascorbi
I
,
Hellweg
R
,
Deicke
U
,
Weise
L
,
Müller-Oerlinghausen
B
. Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine? Pharmacopsychiat , 32 :110 –112 . 1999 .
5.
DuBois
D
. Toxicology and overdose of atypical antipsychotic medications in children: Does newer necessarily mean safer? Current Opinion in Pediatrics , 17 :227 –233 . 2005 .
6.
Duggal
HS
,
Gates
C
,
Pathak
P
. Olanzapine-induced neutropenia: Mechanism and treatment . J Clin Psychopharmacol , 24 :234 –235 . 2004 .
7.
Duggal
,
Singh
I
. Psychotropic drug-induced neutropenia . Drugs Today , 41 :517 –526 . 2005 .
8.
Flanagan
R
,
Dunk
L
. Haematological toxicity of drugs used in psychiatry . Human Psychopharmacol , 23 :27 –41 . 2008 .
9.
Kodesh
A
,
Finkel
B
,
Lerner
AG
,
Kretzmer
G
,
Sigal
M
. Dose-dependent olanzapine-associated leucopenia: Three case reports . Int Clin Psychopharmacol , 16 :117 –119 . 2001 .
10.
Kumar
A
,
Choudhuri
G
,
Aggarwal
R
. Piperacillin induced bone marrow suppression: A case report . BMC Clin Pharmacol , 3 ,2 2003 .
11.
Meltzer
HY
,
Fibiger
H
. Olanzapine: A new atypical antipsychotic drug . Neuropsychopharmacology , 14 :83 –85 . 1996 .
12.
Naumann
R
,
Felber
W
,
Heilemann
H
,
Reuster
T
. Olanzapine-induced agranulocytosis . Lancet , 354 :566 –567 . 1999 .
13.
Peralta
FG
,
Sánchez
MB
,
Roíz
MP
,
Pena
MA
,
Tejero
MA
,
Arjona
R
. Incidence of neutropenia during treatment of bone-related infections with pipercillin-tazobactam . Clin Infect Dis , 37 :1568 –1572 . 2003 .
14.
Rettenbacher
MA
,
Hofer
A
,
Kemmler
G
,
Fleischhacker
WW
. Neutropenia induced by second generation antipsychotics: A prospective investigation . Pharmacopsychaitry , 43 :41 –44 . 2010 .
15.
Scheetz
MH
,
McKoy
JM
,
Parada
JP
,
Djulbegovic
B
,
Raisch
DW
,
Yarnold
PR
,
Zagory
J
,
Trifilio
S
,
Jakiche
R
,
Palella
F
,
Kahn
A
,
Chandler
K
,
Bennett
CL
. Systematic review of piperacillin-induced neutropenia . Drug Safety , 30 :295 –306 . 2007 .
16.
Stergiou
V
,
Bozikas
VP
,
Garyfallos
G
,
Nikolaidis
N
,
Lavrentiadis
G
,
Fokas
K
. Olanzapine-induced leucopenia and neutropenia . Prog Neuropsychopharmacol Biol Psychiatry , 29 :992 –994 . 2005 .
17.
Stip
E
,
Langlois
R
,
Thuot
C
,
Mancini-Marie
A
. Fatal agranulocytosis: The use of olanzapine in a patient with schizophrenia and myelopdysplasia . Progress in Neuro-Psychopharmacology and Biological Psychiatry , 31 :297 –300 . 2007 .
18.
Su
JA
,
Wu
CH
,
Tsang
HY
. Olanzapine-induced agranulocytosis in systemic lupus erythematosus: A case report . General Hospital Psychiatry , 29 :75 –77 . 2007 .
19.
Tolosa-Vilella
C
,
Ruiz-Ripoll
A
,
Mari-Alfonso
B
,
Naval-Sendra
E
. Olanzapine-induced agranulocytosis: A case report and review of the literature . Prog Neuropsychopharmacol Biol Psychiatry , 26 :411 –414 . 2002 .
20.
Wray
CM
,
Stzuke-Fournier
A
. Olanzapine: Hematological reactions . Can Med Assoc J , 159 :81 –82 . 1998 .